Fig. 6From: The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritisEffect of vehicle or MIV-711 (30 µmol/kg) on a urinary levels of CTX-I, b urinary levels of CTX-II and c synovial levels of CTX-II at necropsy (Day 28). Mean ± SEM, n = 15, **p < 0.01, ***p < 0.001 vs. baseline in a, b and **p < 0.01 vs. vehicle in cBack to article page